Institut Claudius Regaud / Oncopole / CHU Toulouse

TOULOUSE 6 trials 2 recruiting

6 Registered trials

2 Currently recruiting

Organisation

Institut Claudius Regaud / Oncopole / CHU Toulouse

Location

TOULOUSE, France

Identifier

ORL-000004825

Address

1 Avenue Irène Joliot Curie, 31059, France

Departments

Medical Oncology
ONCOLOGIE
Pneumologie
Radiotherapy

Clinical trials at this site (6)

Search interface

Evaluation study of a treatement with Nivolumab and Ipilimumab or tKi according to molecular group in naïve metastatic Kidney cancer Pending

2024-520045-23-00 Kidney cancer 4
A Phase 1/2 Study of the Highly Selective ROS1 Inhibitor NVL-520 in Patients with Advanced NSCLC and Other Solid Tumors (ARROS-1) Recruiting

2024-511793-71-00 Advanced ROS1-positive NSCLC and other advanced ROS1-po 7 2022-02-28
Phase 2, Open label Study of Patritumab Deruxtecan (U3-1402), an Anti-HER3-Antibody Drug Conjugate (ADC), in patients with Advanced Breast C… Recruiting

2023-505923-30-00 Patients with hormone-receptor positive (HR+) and human 4 2021-05-11
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neck Ended

2024-513206-65-00 resected squamous cell carcinoma of head and neck 5 2018-08-10
EPI-7386 in Combination with Enzalutamide versus Enzalutamide alone in Metastatic Castration-Resistant Prostate Cancer Ended

2023-509336-25-00 Metastatic castration-resistant prostate cancer 9 2024-06-12
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer Ended

2023-506922-35-00 Locally Advanced or Metastatic Solid Tumors with EGFR a 1 2022-01-24